UiPath (NYSE: PATH) reported quarterly financial results that disappointed stock market investors. Start Your Mornings ...
EverSource Wealth Advisors LLC raised its stake in UiPath Inc. (NYSE:PATH – Free Report) by 141.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional ...
UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.
UiPath (NYSE:PATH – Free Report) had its price target cut by Canaccord Genuity Group from $19.00 to $14.00 in a research ...
UiPath(NYSE: PATH) reported quarterly financial results that disappointed stock market investors. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best ...
Cathie Wood’s ARK ETFs made some significant trades on Tuesday, including selling of Meta Platforms’ (META) stock, while boosting its ...
Canadian investors could consider owning beaten-down AI stocks such as AMD to generate outsized gains in the next 12 months.
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
On Friday, BMO Capital Markets revised its price target for UiPath Inc. (NYSE:PATH) shares, reducing it to $11.50 from the ...
In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results